Ultrasound contrast agents are currently being evaluated for many potential clinical applications. One such application is in patients with indeterminate renal masses. Patients who do not have simple cysts by sonographic criteria often undergo multiple imaging procedures or intervention to achieve a diagnosis. This study examined the impact of the addition of an intravenous contrast agent on sonographic imaging in patients who had renal masses. This study was performed utilizing solely fundamental imaging and the continued evolution of contrast-specific software coupled with intravenous ultrasound contrast agents has the potential to increase diagnostic capabilities in sonography of renal pathology.
References
1.
1. Bosniak MA: The small (< 3.0 cm) renal parenchymal tumor: Detection, diagnosis and controversies. Radiology1991;179:307-317.
2.
2. Gramiak R, Shah PM: Echocardiography of the aortic root. Invest Radiol1969;3:356-366.
3.
3. Goldberg BB, Liu JB, Forsberg F: Ultrasound contrast agents: A review. Ultrasound Med Biol1994;20:319-319.
4.
4. Sehgal CM, Arger PH, Pugh CR: Sonographic enhancement of the renal cortex by contrast media. J Ultrasound Med1995;14:741-748.
6. Kim AY, Kim SH, Kim YS, et al: Contrast enhanced power Doppler sonography for the differentiation of cystic renal lesions. I Ultrasound Med1999;18:581-588.
7.
7. Forsberg F, Liu JB, Merton DA, et al: Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med1995;14: 949-957.
8.
8. Weskott HP, Brands A: Transpulmonary ultrasound con- trast agent helps to characterize small renal masses. Radiology1997;205:242-242.
9.
9. Burns PN, Powers JE, Fritzsch T. Harmonic imaging: A new imaging and Doppler method for contrast enhanced ultrasound. Radiology1992;185:42-42.
10.
10. Burns PN, Wilson SR, Muradali D, et al: Intermittent US harmonic contrast enhanced imaging and Doppler improves sensitivity and longevity of small vessel detection. Radiology1996;201:159-159.
